Clinical Trial Update: A Phase IV Study of Huazhi Rougan Granule [Phase 4]

View source ↗

Summary

Phase IV trial investigating efficacy and safety of Huazhi Rougan Granule for non-alcoholic fatty liver disease has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Fatty Liver Disease

Drugs mentioned

• Huazhi Rougan Granule

Snippet

Sponsor: Shandong New Time Pharmaceutical Co., LTD | Conditions: A Phase IV Trial to Investigate the Efficacy and Safety of Huazhi Rougan Granule in the Treatment of Non-alcoholic Simple Fatty Liver | Phase 4 | Status: COMPLETED